Skip to main content
. 2018 Jan 26;9(2):128. doi: 10.1038/s41419-017-0141-1

Fig. 5. SAA-iPSC-derived-hematopoietic progenitors show a reduced proliferation capacity.

Fig. 5

a Schematic of the experimental design used to analyze the proliferation, DNA repair capacity and apoptosis in SAA-iPSC-derived-hematopoietic progenitors; b Analysis of BrdU-incorporating cells in WT and SAA iPSC-derived-hematopoietic progenitors. One-way ANOVA with Dunnett’s multiple comparison test was used for statistical comparison between WT and SAA cell lines; c Analysis of γH2AX in BrdU+ cells in untreated (dark blue bars), 1 h after HU recovery (beige bars) and 24 h after HU recovery (red bars) iPSC-derived-hematopoietic progenitors. One-way ANOVA with Tukey’s multiple comparison test was used for statistical comparison between untreated cells and 1 h after HU recovery and 24 h after recovery; d Analysis of γH2AX in BrdU+ cells in WT and SAA iPSC-derived-hematopoietic progenitors. One-way ANOVA with Dunnett’s multiple comparison test was used for statistical comparison between WT and SAA cell lines; e Analysis of γH2AX in BrdU- cells in untreated (dark blue bars), 1 h after HU recovery (beige bars) and 24 h after HU recovery (red bars) iPSC-derived-hematopoietic progenitors. One-way ANOVA with Tukey’s multiple comparison test was used for statistical comparison between untreated cells and 1 h after HU recovery and 24 h after recovery,(*p < 0.05); f Analysis of γH2AX in BrdU- cells in WT and SAA iPSC-derived-hematopoietic progenitors. One-way ANOVA with Dunnett’s multiple comparison test was used for statistical comparison between WT and SAA cell lines. bf data is presented as mean of at least 3 independent experiments ± S.E.M. Data for all control cell lines is averaged in one group (WT)